SCHEMBL9099731

SCHEMBL9099731

Nc1ccc2ccc([C]=O)cc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.48
▸ CYP3A4 P08684 3/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ CASP1 P29466 2/20 0.46
▸ CASP7 P55210 2/20 0.46
▸ HBB P68871 2/20 0.46
▸ HIF1A Q16665 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ MAPT P10636 4/20 0.40
▸ PLAU P00749 2/20 0.38
▸ APP P05067 1/20 0.37
▸ LMNA P02545 3/20 0.37
▸ HTT P42858 3/20 0.37
▸ F2 P00734 1/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2346917 0.93 ALDH1A1 (0.50) ALDH1A1CYP3A4HSD17B10CASP1CASP7
SCHEMBL5182331 0.86 CYP1A2 (0.35) CA2
SCHEMBL689299 0.78 ALDH1A1 (0.48) ALDH1A1CYP3A4HSD17B10CASP1CASP7
SCHEMBL4022260 0.78 ASIC3 (0.33) PLAUF2CA2
SCHEMBL202182 0.78 ALDH1A1 (0.72) ALDH1A1CYP3A4HSD17B10CASP1CASP7
SCHEMBL29468144 0.78 ALDH1A1 (0.72) ALDH1A1CYP3A4HSD17B10CASP1CASP7
SCHEMBL3412594 0.75 ALDH1A1 (0.78) ALDH1A1CYP3A4HSD17B10CASP1CASP7
SCHEMBL69325 0.75 CES2 (0.43) ALDH1A1CYP3A4HSD17B10TDP1MAPT
SCHEMBL9098829 0.74 ESR1 (0.48) CYP3A4HSD17B10HIF1AALOX15TDP1
SCHEMBL475597 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0323441-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1996-04-24 — — EP disclosed
EP-0436902-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1995-06-28 — — EP disclosed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 — — US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 — — EP disclosed
EP-0180897-B1 5-FLUOROURACIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-08-07 — — EP disclosed
EP-0436902-A1 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-07-17 — — EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 — — US disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 — — US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 — — EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 — — EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 — — EP disclosed
Send feedback